Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

NCT00004139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: docetaxel
DRUG: gemcitabine hydrochloride
DRUG: irinotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]